BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 3181485)

  • 1. The effects of progesterone receptor blockade in the luteal phase of normal fertile women.
    Li TC; Dockery P; Thomas P; Rogers AW; Lenton EA; Cooke ID
    Fertil Steril; 1988 Nov; 50(5):732-42. PubMed ID: 3181485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
    Greene KE; Kettel LM; Yen SS
    Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of anti-progesterones as a medical IUD.
    Nieman LK; Loriaux DL
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why does RU486 fail to prevent implantation despite success in inducing menstruation?
    Li TC; Lenton EA; Dockery P; Rogers AW; Cooke ID
    Contraception; 1988 Oct; 38(4):401-6. PubMed ID: 3208514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of the antiprogesterone RU486 (Mifepristone) on an endometrial secretory glycan: an immunocytochemical study.
    Graham RA; Li TC; Seif MW; Aplin JD; Cooke ID
    Fertil Steril; 1991 Jun; 55(6):1132-6. PubMed ID: 1709886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase.
    Gemzell-Danielsson K; Svalander P; Swahn ML; Johannisson E; Bygdeman M
    Hum Reprod; 1994 Dec; 9(12):2398-404. PubMed ID: 7714164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Swahn ML; Bygdeman M; Cekan S; Xing S; Masironi B; Johannisson E
    Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
    Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
    Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteal contraception.
    Yen S; Garzo G; Liu J
    Contraception; 1987; 36 Suppl():13-25. PubMed ID: 2824125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late luteal administration of the antiprogesterone RU486 in normal women: effects on the menstrual cycle events and fertility control in a long-term study.
    Couzinet B; Le Strat N; Silvestre L; Schaison G
    Fertil Steril; 1990 Dec; 54(6):1039-44. PubMed ID: 2245828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a single dose of mifepristone (RU486) on the fine structure of the human endometrium during the early luteal phase.
    Dockery P; Ismail RM; Li TC; Warren MA; Cooke ID
    Hum Reprod; 1997 Aug; 12(8):1778-84. PubMed ID: 9308811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action of RU 486.
    Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.